发明申请
US20150119396A9 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
有权
（HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS
- 专利标题： (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- 专利标题（中）： （HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS
-
申请号： US14352719申请日： 2012-10-22
-
公开(公告)号： US20150119396A9公开(公告)日： 2015-04-30
- 发明人: Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estiarte Martínez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria
- 申请人： ORYZON GENOMICS, S.A.
- 优先权： EP11382324.9 20111020; EP11382329.8 20111027
- 国际申请： PCT/EP2012/070900 WO 20121022
- 主分类号： C07C211/36
- IPC分类号： C07C211/36 ; C07C209/28 ; C07D295/135 ; C07D213/38 ; C07C275/26 ; C07D207/14 ; C07C271/24 ; C07C273/18 ; C07C211/38 ; C07C269/00 ; C07D277/28
摘要：
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and theft use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
公开/授权文献
- US09469597B2 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors 公开/授权日：2016-10-18
信息查询
